Researchers discovered combining the brain-penetrating antipsychotic drug pimozide with a clinically investigative glutamine metabolism inhibitor, CB-839, can overcome tumor resistance and effectively suppress GBM growth.
Read more https://www.sciencedaily.com/releases/2024/10/241007160255.htm